SB 1724 - This act makes xylazine a Schedule III controlled substance, except for certain uses described in the act, including manufacturing a drug for an animal or administering the drug to an animal.
This act is substantially similar to HB 1881 (2026). SARAH HASKINS
- Chamber
- Senate
- Introduced
- Feb 25, 2026
- Last action
- Feb 25, 2026 — S First Read
- Session
- 2026
- Momentum
- 39 · Low